Skip to content
Medium cut-off hemodialysis in multiple myeloma-associated cast nephropathy: A single-center experience
All contributors

Onconephrology contributor

Azoulay, Elie

Primarily Tumor lysis & electrolytes#44 of 47 recognized
  • #3 in Tumor lysis & electrolytes
9
Clinical papers
337
Citations (iCite)
0 / 4
First / senior author
2010–2022
Active years

Output over time

Clinical corpus papers per year — peak 3 in 2015.

  • 2010: 1 paper
  • 2013: 1 paper
  • 2014: 1 paper
  • 2015: 3 papers
  • 2018: 1 paper
  • 2021: 1 paper
  • 2022: 1 paper
20102022

Subfield mix

Clinical papers by onconephrology subfield (a paper can count in more than one).

Tumor lysis & electrolytes7
Anticancer drug nephrotoxicity4
Cellular therapy renal effects1

Frequent collaborators

Other recognized contributors who most often share corpus papers with Azoulay (shared-paper count).

Zafrani, Lara5

Verify

Representative recent papers, and this author’s full PubMed bibliography.

PMID 36552755 (opens PubMed in a new tab)PMID 33836884 (opens PubMed in a new tab)PMID 29579262 (opens PubMed in a new tab)PMID 27476311 (opens PubMed in a new tab)PMID 25480521 (opens PubMed in a new tab)PMID 25098426 (opens PubMed in a new tab)All papers on PubMed

A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,329-article corpus (regenerated 2026-08-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.